Comprehesive DNA methylation profiling reveals novel biomarkers and potential pathways in epithelial ovarian cancer.

This study showed that MeDIP-seq could be used for methylation profiling in an efficient manner and identified a number of potential hub genes and pathways important in the ovarian cancer carcinogenesis that may deepen our understanding of the molecular mechanisms involved inthe development of ovarian cancer. DNA methylation profiling of 3 normal, 1 benign and 4 ovarian cancer samples.